Official Title: A Multi-Center Randomized Parallel Dose-Finding Safety Assessor-Blinded Trial to Explore the Efficacy Safety and Pharmacokinetics of Four Doses of Org 25969 and Placebo in Pediatric and Adult Subjects
Status: COMPLETED
Status Verified Date: 2018-08
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: The purpose of this study is
to explore the dose-response relation of sugammadex Org 25969 MK-8616 SCH 900616 given as a reversal agent at reappearance of T2 after 06 mgkg-1 rocuronium in pediatric and adult participants to explore the pharmacokinetics PK of sugammadex in pediatric and adult participants and to evaluate the safety of sugammadex in pediatric and adult participants